Ophthalmology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

  • Single User License $3500

Ophthalmology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2028

Status : August, 2020 | Pharmaceutical | PPT format

Report Digest

The global ophthalmology is expected to grow at a steady rate during the forecast period. There are various that stimulate the expansion of ophthalmology therapeutics. Rising awareness about eye care and ocular disorder are anticipated to drive the global ophthalmology market to grow in the projected years.

TMR research report foretells about the size, share, trend, growth factors, and restraints affecting the global ophthalmology market. The report also sheds light on geographical and recent development in the market.

Ophthalmology Therapeutics Market: Notable Developments

The recent developments in the global ophthalmology therapeutic market are:

  • In June 2019, OCTANE’s Sixth Summit for ophthalmology technology showcased the technological advances in the field. The summit was attended by Cell Care Therapeutics, Len Techs, VisgenX, and IACTA. The aim of the summit was to bring in all physicians, ophthalmology drugs companies and investors together and facilitate partnership.
  • In April 2019, The American Academy of Ophthalmology honored three congress members of the United States for their exemplary contribution in preserving the access to enhanced eye care and treatments for the patients. This is award is known as Visionary Award, 2019.

Some of the most prominent competitors operating in the competitive landscape of global ophthalmology therapeutics market include –

  • Bausch & Lomb, Inc.
  • Regeneron Pharmaceuticals, Inc.
  • Novartis AG
  • Santen Pharmaceutical Co., Ltd.
  • Johnson & Johnson Services, Inc
  • Genentech, Inc. and Pfizer, Inc.

Ophthalmology Therapeutics Market: Drivers and Restraints

The factors leading the global ophthalmology therapeutics market to expand are :

Geriatric Population to Drive Global Ophthalmology Therapeutics Market

The growing number of geriatric population is expected to drive the growth in the global ophthalmology therapeutics market in the future. Due to the age factor the number of eye related diseases crop up such as glaucoma, cataract, etc., aiding in the expansion of the ophthalmology market.

Additionally, rising number of chronic ocular disorders such as macular edema, and macular degeneration are anticipated to push the global ophthalmology market to expand during the forecast period.

Further, eye disorders such as diabetic retinopathy, widespread of seasonal eye infections such as conjunctivitis and enhanced treatments are projected to drive the global ophthalmology therapeutics market in the near future.

Novel Drug Delivery System to Stimulate Growth

The increasing research and development has led to several novel drug developments in the ophthalmology therapeutics market. This is expected to expand the global ophthalmology therapeutics market in the upcoming years.

On the basis of segmentation the global ophthalmology therapeutics market is divided into over the counter (OTC) drugs and prescribed drugs. Among these, the prescribed drugs segment is projected to hold a major share in the market during the forecast period.

On the basis of disease types, the global ophthalmology therapeutics market is divided into glaucoma, dry eye, infections, uveitis, allergies and retinal disorders. But, retinal disorders are projected to register a higher growth in the global gy therapeutics market.

Ophthalmology Therapeutics Market: Geographical Analysis

Previously, North America is held the global ophthalmology therapeutics market and it is likely to remain dominant during the forecast period. The growth here is attributable to rising number of eye disorder, growing geriatric population. Additionally, Asia Pacific is anticipated to showcase a surge in the growth over the forecast period. The growth is expected to be due to rising awareness about eye care, rising disposable income, and presence of better medical infrastructure.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.